Журнал «Медицина неотложных состояний» Том 21, №8, 2025

Актуальність. В умовах воєнного стану в Україні надання спеціалізованої онкологічної допомоги, зокрема променевої терапії, суттєво ускладнюється. Жінки з раком молочної залози потребують безперервного лікування, порушення якого може призвести до рецидивів і зниження виживаності. Мета: проаналізувати результати надання променевої терапії хворим на рак молочної залози в умовах невідкладних ситуацій (військові дії, евакуація, обмежений доступ до обладнання). Матеріали та методи. Проведено ретроспективний аналіз 42 пацієнток з І–ІІІ стадією раку молочної залози, які проходили курс променевої терапії у ІМРО у період активних бойових дій 2022–2024 рр. Результати. У 83 % випадків застосовано гіпофракціоновані схеми (40 Гр за 15 фракцій), що дозволило скоротити час лікування. В 11 % пацієнток лікування переривалося через тривоги або перебої з електропостачанням, проте у всіх вдалося завершити курс променевої терапії за адаптованими протоколами. Висновки. Гнучкість підходів до фракціонування, міждисциплінарна співпраця та мобільність персоналу дозволяють забезпечити ефективну та безпечну променеву терапію хворим на рак молочної залози навіть в умовах невідкладних ситуацій.

Background. Under martial law in Ukraine, the provision of specialized oncological care, particularly radiation therapy, is significantly complicated. Women with breast cancer require continuous treatment, and any interruption may lead to recurrences and decreased survival. Purpose: to analyze the outcomes of radiation therapy in breast cancer patients under emergency conditions (military actions, evacuation, limited access to equipment). Materials and methods. A retrospective analysis was conducted of 42 patients with stage I–III breast cancer who underwent radiation therapy at the Grigoriev Institute for Medical Radiology and Oncology during the period of active hostilities in 2022–2024. Results. In 83 % of cases, hypofractionated regimens (40 Gy in 15 fractions) were applied, which allowed for a reduction in treatment duration. In 11 % of women, treatment was interrupted due to air raids or power outages; however, all patients were able to complete their radiation therapy course using adapted protocols. Conclusions. Flexibility in fractionation approaches, interdisciplinary collaboration, and staff mobility ensure effective and safe radiation therapy for breast cancer patients even under emergency conditions.

рак молочної залози; променева терапія; гіпофракціонування; надзвичайні ситуації; ­війна; онкологічна допомога

breast cancer; radiation therapy; hypofractionation; emergencies; war; oncological care

1. Hbert-Croteau N, Freeman C, Latreille, J. Delay in adjuvant radiation treatment and outcomes of breast cancer — a review. Breast Cancer Res Treat. 2002;74:77-94. https://doi.org/10.1023/A:1016089215070. 
2. Bese NS, Hendry J, Jeremic B. Effects of prolongation of ove–rall treatment time due to unplanned interruptions during radiothe–rapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys. 2007;68(3):654-61. doi: 10.1016/j.ijrobp.2007.03.010. PMID: 17467926. 
3. Braunstein LZ, Gillespie EF, Hong L, et al. Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints-Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States. Adv Radiat Oncol. 2020;5(4):582-588. doi: 10.1016/j.adro.2020.03.013. PMID: 32292842; PMCID: PMC7118660. 
4. Slotman BJ, Lievens Y, Poortmans P, et al. Effect of COVID-19 pandemic on practice in European radiation oncology centers. Radiother Oncol. 2020;150:40-42. doi: 10.1016/j.radonc.2020.06.007. PMID: 32544604; PMCID: PMC7292946. 
5. Smith BD, Bellon JR, Blitzblau R, et al. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018;8(3):145-152. doi: 10.1016/j.prro.2018.01.012. PMID: 29545124. 
6. Rudat V, Zhao R, Wang B, et al. Impact of deep inspiration breath hold, surface-guided radiotherapy, and daily CBCT on the organs at risk in breast cancer radiotherapy. Sci Rep. 2024;14. https://doi.org/10.1038/s41598-024-77482-8. 
7. Offersen BV, Boersma LJ, Kirkove C, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015;114(1):3-10. doi: 10.1016/j.radonc.2014.11.030. PMID: 25630428. 
8. Alsaihaty Z, Abdul Manan H, Sabarudin A, Yahya N. Hybrid Treatment Planning for Chest Wall Irradiation Utilizing Three-Dimensional Conformal Radiotherapy (3DCRT), Intensity-Modulated Radiation Therapy (IMRT), and Volumetric Modulated Arc The–rapy (VMAT): A Systematic Review. Cureus. 2024;16(5):e59583. doi: 10.7759/cureus.59583. PMID: 38832195. PMCID: PMC11144584. 
9. Caglevic C, Rolfo C, Gil-Bazo I, et al. The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations. JCO Glob Oncol 2022;8:e2200123. doi: 10.1200/GO.22.00123. PMID: 35994695. PMCID: PMC9470147. 
10. Janssens GO, Mandeville HC, Timmermann B, et al. A rapid review of evidence and recommendations from the SIOPE radiation oncology working group to help mitigate for reduced pediatric radiotherapy capacity during the Covid 19 pandemic or other crises. Radiother Oncol. 2020;148:216-222. doi: 10.1016/j.radonc.2020.04.035. 
11. Franco P, Kochbati L, Siano M, De Bari B. Suggestions for Radiation Oncologists during the COVID-19 Pande–mic. Biomed Research International. 2020;2020:е4892382. doi: 10.1155/2020/4892382. PMID: 32509860. PMCID: PMC7254074. 
12. Fujita M, Nagashima K, Uno T, et al. Impact of the –COVID-19 Pandemic on Hypofractionated Radiation Therapy Use for Breast Cancer in Japan: A Nationwide Study. Adv Radiat Oncol. 2024;9:е101555. doi: 10.1016/j.adro.2024.101555. PMID: 39104876. PMCID: PMC11298581.
13. Spencer K, Jones CM, Girdler R, et al. The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a po–pulation-based study. Lancet Oncol. 2021;22:309-320. doi: 10.1016/S1470-2045(20)30743-9. 
14. Al-Rashdan A, Roumeliotis M, Quirk S, et al. Adapting Radiation Therapy Treatments for Patients with Breast Cancer During the 
15. COVID-19 Pandemic: Hypo-Fractionation and Accelerated Partial Breast Irradiation to Address World Health Organization Recommendations. Adv Radiat Oncol. 2020;5:575-576. doi: 10.1016/j.adro.2020.03.011. PMID: 32363244. PMCID: PMC7194663. 
16. Knowlton CA. Breast Cancer Management During the –COVID-19 Pandemic: the Radiation Oncology Perspective. Curr Breast Cancer Rep. 2022;14:8-16. doi: 10.1007/s12609-022-00441-7. PMID: 35251487. PMCID: PMC8881209.
17. Ahmed Y. Enhancing Cancer Care Amid Conflict: A Proposal for Optimizing Oncology Services During Wartime. JCO Glob Oncol. 2023;9:e2300304. doi: 10.1200/GO.23.00304. PMID: 38085039. PMCID: PMC10846788.
18. Al-Ibraheem A, Abdlkadir AS, Mohamedkhair A, Mikhail-Lette M, Al-Qudah M, Paez D, Mansour AH. Cancer diagnosis in areas of conflict. Front Oncol. 2022;12:е1087476. doi: 10.3389/fonc.2022.1087476. PMID: 36620568. 
19. Shamieh O, Kutluk T, Fouad FM, Sullivan R, Mansour A. Cancer care in areas of conflict. Front. Oncol. 2023;13:152. doi: 10.3389/fonc.2023.1301552.
20. Brunt AM, Haviland JS, Sydenham M, et al. A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer. J Clin Oncol. 2020;38(28):3261-3272. doi: 10.1200/JCO.19.02750. 
21. Eraso A, Sanz J, Moll M, et al. Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group. Clin Transl Oncol. 2022;24(8):1580-1587. doi: 10.1007/s12094-022-02798-8. 
22. Meattini I, Marrazzo L, Saieva C, et al. Accelerated Partial-Breast Irradiation Compared With Whole-Breast Irradiation for Early Breast Cancer: Long-Term Results of the Randomized Phase III APBI-IMRT-Florence Trial. J Clin Oncol. 2020;38:4175-4183. doi: 10.1200/JCO.20.00650.